Skip to main content
. 2021 Dec 22;14(1):14. doi: 10.3390/pharmaceutics14010014

Figure 3.

Figure 3

Scheme showing folic acid- and FR-targeted formulations internalization. Folic acid or another ligand binds to folate receptor (A). An invagination of the plasma membrane is generated (B) and the folate receptor-ligand conjugate is enclosed in a vesicle named endosome (C), where the acidic pH triggers conformational changes in the folate receptors, inducing the release of the ligand (D) and the drug into the cells, and the recycling of the folate receptor to the cell surface (E,F).